NCT03692494

Brief Summary

Evaluate if adding expiratory muscle strength training to traditional voice therapy for individuals with dysphonia due to glottal insufficiency improves maximal expiratory pressure, acoustic and aerodynamic measures (i.e. amplitude, maximum phonation time, peak expiratory flow), and voice related quality of life.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
7mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Apr 2025Dec 2026

First Submitted

Initial submission to the registry

September 26, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 2, 2018

Completed
6.5 years until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

February 7, 2025

Status Verified

February 1, 2025

Enrollment Period

1.7 years

First QC Date

September 26, 2018

Last Update Submit

February 4, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Maximum expiratory pressure

    Maximum expiratory pressure, in cm of H2O, will be measured to evaluate how much pressure a participant can blow into a respiratory pressure meter.

    16 weeks

  • Amplitude

    Amplitude of voice, in decibels, will be measured using Voice Range Profile on Kay Pentax CSL and will be compared to gender matched normative values for normal and loud volumes.

    16 weeks

Secondary Outcomes (7)

  • Fundamental frequency

    16 weeks

  • Dynamic pitch range

    16 weeks

  • Cepstral Peak Prominence (CPP)

    16 weeks

  • Cepstral spectral index of dysphonia (CSID)

    16 weeks

  • Voice Handicap Index

    16 weeks

  • +2 more secondary outcomes

Study Arms (3)

Unilateral vocal fold paralysis standard of care voice therapy

EXPERIMENTAL

The participants will receive the standard of voice therapy including improved breath coordination, sustained humming and vowels, vocal glides, resonant voice therapy, and relations techniques.

Other: Standard of care voice therapy

Unilateral paralysis standard of care voice therapy plus EMST

EXPERIMENTAL

The participants will receive the standard of voice therapy including improved breath coordination, sustained humming and vowels, vocal glides, resonant voice therapy, and relations techniques. EMST consists of blowing into respiratory device at a measure threshold pressure. As strength improves threshold resistance will be increased.

Other: Standard of care voice therapyOther: Expiratory muscle strength training (EMST)

Parkinson's disease standard of care voice therapy plus EMST

EXPERIMENTAL

The participants will receive the standard of voice therapy including improved breath coordination, sustained humming and vowels, vocal glides, resonant voice therapy, and relations techniques. EMST consists of blowing into respiratory device at a measure threshold pressure. As strength improves threshold resistance will be increased.

Other: Standard of care voice therapyOther: Expiratory muscle strength training (EMST)

Interventions

Exercises will include improved breath coordination, sustained humming and vowels, vocal glides, resonant voice therapy, and relaxation techniques to the neck and shoulder

Parkinson's disease standard of care voice therapy plus EMSTUnilateral paralysis standard of care voice therapy plus EMSTUnilateral vocal fold paralysis standard of care voice therapy

EMST150 used at 75% of their maximum expiratory pressure. Participants will be directed to perform 5 sets of 5 breaths, 5 days per week, for 5 weeks, at the pressure threshold established in therapy. Maximum expiratory pressure will then be determined at the beginning of each therapy session and recalibration of the device will be performed if indicated.

Parkinson's disease standard of care voice therapy plus EMSTUnilateral paralysis standard of care voice therapy plus EMST

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals with glottic insufficiency.
  • Adequate cognition evidenced by score of 24 or higher on the Mini-Mental State Examination (MMSE) survey to determine if the subject has the mental capacity to participate in therapy
  • Completed voice combination evaluation with speech pathologists and otolaryngologist.
  • Individuals 18 years of age or older

You may not qualify if:

  • Adults unable to consent
  • Non English or Spanish speakers
  • Pregnant women
  • Prisoners
  • Individuals with significant uncontrolled chronic and progressive respiratory diseases including COPD, interstitial lung disease, and cystic fibrosis.
  • Individuals with uncontrolled blood pressure.
  • Individuals with significant GI disease and/or gastroesophageal surgery with the exception of well-controlled GERD.
  • Individuals with a history of abdominal hernia.
  • Individuals with difficulty complying due to neuropsychological dysfunction (e.g., severe depression, psychosis).
  • Individuals with other neurological disorders and/or neuromuscular disease other than Parkinson's Disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami

Miami, Florida, 33136, United States

Location

MeSH Terms

Conditions

DysphoniaVocal Cord Paralysis

Condition Hierarchy (Ancestors)

Voice DisordersLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsVagus Nerve DiseasesCranial Nerve DiseasesParalysis

Study Officials

  • Adam T Lloyd, SLP-D, MM, MA

    University of Miami

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Speech Pathologist

Study Record Dates

First Submitted

September 26, 2018

First Posted

October 2, 2018

Study Start

April 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

February 7, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations